{
    "symbol": "VTVT",
    "name": "vTv Therapeutics Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "country": "USA",
    "exchange": "NASD",
    "statements": {
        "Income Statement": {
            "Dates": [
                "TTM",
                "12/31/2021",
                "12/31/2020",
                "12/31/2019",
                "12/31/2018",
                "12/31/2017",
                "12/31/2016",
                "12/31/2015"
            ],
            "Total Revenue": [
                "2.02",
                "4.00",
                "6.41"
            ],
            "Cost of Revenue": [
                "",
                "",
                ""
            ],
            "Gross Profit": [
                "",
                "",
                ""
            ],
            "Selling General and Administrative": [
                "15.53",
                "11.44",
                "7.25"
            ],
            "Research and Development": [
                "13.79",
                "12.62",
                "11.02"
            ],
            "Unusual Expense/Income": [
                "",
                "1.60",
                ""
            ],
            "Total Operating Expense": [
                "29.32",
                "25.67",
                "18.27"
            ],
            "Operating Income": [
                "-27.31",
                "-21.66",
                "-11.85"
            ],
            "Interest Income Net": [
                "0.18",
                "-0.01",
                "-0.68"
            ],
            "Other Income Net": [
                "-1.15",
                "4.06",
                "-0.27"
            ],
            "Net Income Before Taxes": [
                "-28.27",
                "-17.62",
                "-12.80"
            ],
            "Provision for Income Taxes": [
                "0.20",
                "0.12",
                "0.00"
            ],
            "Net Income": [
                "-21.47",
                "-12.99",
                "-8.50"
            ],
            "Income Avail. to Common Excl. Extraord.": [
                "-21.47",
                "-12.99",
                "-8.50"
            ],
            "Income Avail. to Common Incl. Extraord.": [
                "-21.47",
                "-12.99",
                "-8.50"
            ],
            "Diluted Average Shares": [
                "71.13",
                "60.73",
                "47.14"
            ],
            "Diluted EPS Excl. Extraord.": [
                "-0.30807",
                "-0.21384",
                "-0.18030"
            ],
            "Diluted EPS Incl. Extraord.": [
                "-0.30807",
                "-0.21384",
                "-0.18030"
            ]
        },
        "Balance Sheet": {
            "Dates": [
                "TTM",
                "12/31/2021",
                "12/31/2020",
                "12/31/2019",
                "12/31/2018",
                "12/31/2017",
                "12/31/2016",
                "12/31/2015"
            ],
            "Total Revenue": [
                "2.02",
                "4.00",
                "6.41"
            ],
            "Cost of Revenue": [
                "",
                "",
                ""
            ],
            "Gross Profit": [
                "",
                "",
                ""
            ],
            "Selling General and Administrative": [
                "15.53",
                "11.44",
                "7.25"
            ],
            "Research and Development": [
                "13.79",
                "12.62",
                "11.02"
            ],
            "Unusual Expense/Income": [
                "",
                "1.60",
                ""
            ],
            "Total Operating Expense": [
                "29.32",
                "25.67",
                "18.27"
            ],
            "Operating Income": [
                "-27.31",
                "-21.66",
                "-11.85"
            ],
            "Interest Income Net": [
                "0.18",
                "-0.01",
                "-0.68"
            ],
            "Other Income Net": [
                "-1.15",
                "4.06",
                "-0.27"
            ],
            "Net Income Before Taxes": [
                "-28.27",
                "-17.62",
                "-12.80"
            ],
            "Provision for Income Taxes": [
                "0.20",
                "0.12",
                "0.00"
            ],
            "Net Income": [
                "-21.47",
                "-12.99",
                "-8.50"
            ],
            "Income Avail. to Common Excl. Extraord.": [
                "-21.47",
                "-12.99",
                "-8.50"
            ],
            "Income Avail. to Common Incl. Extraord.": [
                "-21.47",
                "-12.99",
                "-8.50"
            ],
            "Diluted Average Shares": [
                "71.13",
                "60.73",
                "47.14"
            ],
            "Diluted EPS Excl. Extraord.": [
                "-0.30807",
                "-0.21384",
                "-0.18030"
            ],
            "Diluted EPS Incl. Extraord.": [
                "-0.30807",
                "-0.21384",
                "-0.18030"
            ]
        },
        "Cash Flow": {
            "Dates": [
                "TTM",
                "12/31/2021",
                "12/31/2020",
                "12/31/2019",
                "12/31/2018",
                "12/31/2017",
                "12/31/2016",
                "12/31/2015"
            ],
            "Total Revenue": [
                "2.02",
                "4.00",
                "6.41"
            ],
            "Cost of Revenue": [
                "",
                "",
                ""
            ],
            "Gross Profit": [
                "",
                "",
                ""
            ],
            "Selling General and Administrative": [
                "15.53",
                "11.44",
                "7.25"
            ],
            "Research and Development": [
                "13.79",
                "12.62",
                "11.02"
            ],
            "Unusual Expense/Income": [
                "",
                "1.60",
                ""
            ],
            "Total Operating Expense": [
                "29.32",
                "25.67",
                "18.27"
            ],
            "Operating Income": [
                "-27.31",
                "-21.66",
                "-11.85"
            ],
            "Interest Income Net": [
                "0.18",
                "-0.01",
                "-0.68"
            ],
            "Other Income Net": [
                "-1.15",
                "4.06",
                "-0.27"
            ],
            "Net Income Before Taxes": [
                "-28.27",
                "-17.62",
                "-12.80"
            ],
            "Provision for Income Taxes": [
                "0.20",
                "0.12",
                "0.00"
            ],
            "Net Income": [
                "-21.47",
                "-12.99",
                "-8.50"
            ],
            "Income Avail. to Common Excl. Extraord.": [
                "-21.47",
                "-12.99",
                "-8.50"
            ],
            "Income Avail. to Common Incl. Extraord.": [
                "-21.47",
                "-12.99",
                "-8.50"
            ],
            "Diluted Average Shares": [
                "71.13",
                "60.73",
                "47.14"
            ],
            "Diluted EPS Excl. Extraord.": [
                "-0.30807",
                "-0.21384",
                "-0.18030"
            ],
            "Diluted EPS Incl. Extraord.": [
                "-0.30807",
                "-0.21384",
                "-0.18030"
            ]
        }
    }
}